Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

How much are hospitals marking up the price of medicines? The answer may surprise you.

October 17, 2017

Hospitals mark up medicine prices, on average, nearly 500 percent, according to a new analysis from the Moran Company that was commissioned by PhRMA.

Read More

Medicare Monday: Open enrollment is here again

October 16, 2017

As of October 15, newly qualified patients and current Medicare beneficiaries can review their coverage options and select their 2018 health plans.

Read More

PhRMA response to Washington Post and 60 Minutes stories

October 16, 2017

The opioid epidemic confronting America is a growing public health crisis from which none of us are immune.

Read More

New Analysis: 340B Program Shifting Delivery of Physician-Administered Medicines to More Expensive Hospital Settings

October 16, 2017

From 2008 to 2015, there was a significant shift in site of care from physician offices to more expensive 340B hospital outpatient settings for certain classes of physician-administered medicines, according to a new analysis by the Berkeley Research Group (BRG) that was commissioned by PhRMA.

Read More

VIDEO: PhRMA CEO discusses industry response to opioid crisis on Mornings with Maria

October 12, 2017

PhRMA president and CEO Stephen J. Ubl joined Fox Business’ Maria Bartiromo on “Mornings with Maria” today to discuss opioid crisis.

Read More

PhRMA, member companies and NIH create public-private partnership for immuno-oncology

October 12, 2017

A new public-private partnership will help build upon a new era in cancer treatment.

Read More

Sharing Negotiated Discounts Could Save Patients More than $800 Annually and Would Increase Premiums About 1 Percent

October 12, 2017

Providing access to discounted medicine prices at the point of sale could save certain commercially insured patients with high deductibles and coinsurance $145 to more than $800 annually, according to a new analysis from Milliman that was commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Read More

Amgen Chairman and CEO Robert A. Bradway Elected PhRMA Board Chairman-Elect

October 11, 2017

The Pharmaceutical Research and Manufacturers of America elected new officers to its board of directors.

Read More

2017 Research & Hope Awards honor innovators in mental health

October 10, 2017

As we honor those who are fighting for better mental health, there are more than 140 medicines in development to treat mental health disorder.

Read More

PhRMA to Present the 2017 Research & Hope Awards for Outstanding Mental Health Advocacy and Research

October 10, 2017

PhRMA today announced the recipients of the 2017 Research & Hope Awards.

Read More